Evidence map›Paper›PMID 26968021›Full record

ArticleCritical care medicine2016

Role of MiR-126a-3p in Endothelial Injury in Endotoxic Mice.

Maoping Chu, Shanshan Qin, Rongzhou Wu, Xiangyu Zhou, Xiaojun Tang, Shuo Zhang, Qifeng Zhao, Huating Wang, Ying Liu, Xiaohua Han and 3 more

Abstract read
In one paragraph

Article in Critical care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Role of miRNA dysregulation in sepsis.Molecular medicine (Cambridge, Mass.) · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Exosomes from Endothelial Progenitor Cells Improve the Outcome of a Murine Model of Sepsis.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Maoping Chu *Children's Heart Center, the Second Affiliated Hospital & Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou, China, 325027.
Shanshan Qin *Department of Pharmacology and Cardiovascular Research Center, Rush Medical College, Rush University Medical Center, Chicago, IL, USA, 60612.
Rongzhou WuChildren's Heart Center, the Second Affiliated Hospital & Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou, China, 325027.
Xiangyu ZhouDepartment of Pharmacology and Cardiovascular Research Center, Rush Medical College, Rush University Medical Center, Chicago, IL, USA, 60612.
Xiaojun TangDepartment of Pharmacology and Cardiovascular Research Center, Rush Medical College, Rush University Medical Center, Chicago, IL, USA, 60612.
Shuo ZhangDepartment of Pharmacology and Cardiovascular Research Center, Rush Medical College, Rush University Medical Center, Chicago, IL, USA, 60612.
Qifeng ZhaoChildren's Heart Center, the Second Affiliated Hospital & Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou, China, 325027.
Huating WangDepartment of Pharmacology and Cardiovascular Research Center, Rush Medical College, Rush University Medical Center, Chicago, IL, USA, 60612.
Ying LiuDepartment of Pharmacology and Cardiovascular Research Center, Rush Medical College, Rush University Medical Center, Chicago, IL, USA, 60612.
Xiaohua HanDepartment of Pharmacology and Cardiovascular Research Center, Rush Medical College, Rush University Medical Center, Chicago, IL, USA, 60612.
Jian XiaoChildren's Heart Center, the Second Affiliated Hospital & Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou, China, 325027.
Xiaokun LiChildren's Heart Center, the Second Affiliated Hospital & Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou, China, 325027.
Chunxiang ZhangDepartment of Pharmacology and Cardiovascular Research Center, Rush Medical College, Rush University Medical Center, Chicago, IL, USA, 60612.
Rush University Medical Center · USWenzhou Medical University · CN

Funding

Role of miR-145 in Vascular Smooth Muscle Cell BiologyRole ofR01HL095707 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ZHANG, CHUNXIANG · 2010 to 2013
$1.5M
GOLPH3 in vascular smooth muscle cell biology and vascular diseaseR01HL130052 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI QIN, GANGJIAN · 2016 to 2019
$1.5M
Circulating cell-free microRNAs in atherogenesisR21HL109656 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI ZHANG, CHUNXIANG · 2012 to 2013
$410k
MicroRNA mechanism and therapeutics of impaired wound healingR21NR013876 · NINR · RUSH UNIVERSITY MEDICAL CENTER · PI ZHANG, CHUNXIANG · 2012 to 2013
$409k
NHLBI NIH HHS R01 HL095707NHLBI NIH HHS R01 HL130052NHLBI NIH HHS R21 HL109656NINR NIH HHS R21 NR013876
6 · The paper itself

Abstract

objectiveSepsis poses a serious global health problem with an overall mortality rate of 30%, in which the vascular injury is a major contributor. The study is to determine the expression profile of micro-RNAs in endotoxic vascular walls and their potential roles in sepsis-related vascular injury.

designProspective randomized study.

settingLaboratory investigation. SUBJECTS: Male C57BL/6 mice, average weight 26.5 ± 1.8 g.

interventionsEndotoxemia was induced in mice via lipopolysaccharide injection (20 mg/kg, intraperitoneal) (Sigma, St. Louis, MO). The control mice were injected with the same amount of saline (500 μL, intraperitoneal). In a subgroup of mice, a high dose of lipopolysaccharide (30 mg/kg, intraperitoneal) was applied to induce endotoxin-related death. MEASUREMENTS AND MAIN

resultsThe mi-RNA expression profiles in aortas from lipopolysaccharide-induced endotoxic mice were determined. The result demonstrated that some micro-RNAs were aberrantly expressed in endotoxic mouse arteries. Among them, the endothelial cell-enriched/endothelial cell-specific miR-126a-3p was significantly down-regulated in endotoxic mouse arteries, septic human vessels, as well as vascular endothelial cells isolated from endotoxic mice or treated with lipopolysaccharide. The down-regulation of miR-126a-3p occurred at transcriptional level via the decreased expression of Krüppel-like factor 2, which could be inhibited by Krüppel-like factor 2 over-expression via adenovirus expressing Krüppel-like factor 2. The down-regulation of miR-126a-3p in endothelial cells resulted in the increased apoptosis, and decreased proliferation and migration, which were inhibited by miR-126a-3p mimics. In vivo, over-expression of miR-126a-3p via lentivirus attenuated endotoxemia-induced injuries on endothelial function and vascular permeability. We found that SPRED1 and VCAM-1 were two direct target genes of miR-126a-3p related to miR-126a-3p-mediated effects in endotoxemia. Finally, the survival rate of endotoxic mice was significantly increased by the over-expression of miR-126a-3p.

conclusionsThe results suggest that vascular micro-RNAs such as miR-126a-3p may represent novel mechanisms and new therapeutic targets for endotoxemia-induced vascular injury and endotoxic mortality.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAortaDisease Models, AnimalDown-RegulationEndothelial CellsEndotoxemiaHumansKruppel-Like Transcription FactorsLipopolysaccharidesMaleMiceMice, Inbred C57BLMicroRNAsProspective StudiesRandom AllocationAdaptor Proteins, Signal TransducingKruppel-Like Transcription FactorsLipopolysaccharidesMicroRNAsRepressor ProteinsSpred1 protein, mouseVascular Cell Adhesion Molecule-1

Identifiers

PMID26968021
PMCPMC4949098
OpenAlexW2334465600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.